BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4272459)

  • 1. NMR-studies on the molecular basis of drug-induced phospholipidosis. Interaction between chlorphentermine and phosphatidylcholine.
    Seydel JK; Wassermann O
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 279(2):207-10. PubMed ID: 4272459
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-induced foam cell reactions in rats. I. Histopathologic and cytochemical observations after treatment with chlorphentermine, RMI 10.393 and Ro 4-4318.
    Karabelnik D; Zbinden G; Baumgartner E
    Toxicol Appl Pharmacol; 1974 Feb; 27(2):395-407. PubMed ID: 4136644
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on animal and organ specificity of chlorphentermine induced morphological alterations (author's transl)].
    Parwaresch R; Reil GH; Seiler KU
    Res Exp Med (Berl); 1973 Nov; 161(4):272-88. PubMed ID: 4358569
    [No Abstract]   [Full Text] [Related]  

  • 4. Chlorphentermine-induced ultrastructural alterations in foetal tissues.
    Lüllmann-Rauch R
    Virchows Arch B Cell Pathol; 1973 Mar; 12(4):295-302. PubMed ID: 4350408
    [No Abstract]   [Full Text] [Related]  

  • 5. [A massive appearance of "foam cells" in rat lungs following chronic administration of chlorphentermine].
    Franken G; Lüllmann H; Siegfriedt A
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):323-4. PubMed ID: 4253764
    [No Abstract]   [Full Text] [Related]  

  • 6. Proceedings: Dose-dependence of chlorphentermine-induced ultrastructural alterations in rat.
    Lüllmann-Rauch R; Reil GH
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R60. PubMed ID: 4276607
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative study of anorectic activity of d-amphetamine, chlorphentermine and fenfluramine in aurothioglucose obese and non-obese mice.
    Abdallah AH
    Arch Int Pharmacodyn Ther; 1968 Dec; 176(2):395-402. PubMed ID: 5715411
    [No Abstract]   [Full Text] [Related]  

  • 8. [Delayed effects of Avipron].
    Chojnowski JR; Adamska-Dyniewska H; Chojnowska-Jezierska J; Goch JH
    Wiad Lek; 1973 May; 26(10):907-12. PubMed ID: 4710730
    [No Abstract]   [Full Text] [Related]  

  • 9. [Electroencephalography in the course of Avipron administration as an appetite depressant].
    Czarnecka E; Gawlik L
    Wiad Lek; 1974 Feb; 27(3):245-8. PubMed ID: 4839700
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of the uptake of noradrenaline and 5-hydroxytryptamine by chlorphentermine and chlorimipramine.
    Ross SB; Renyi AL; Ogren SO
    Eur J Pharmacol; 1972 Jan; 17(1):107-12. PubMed ID: 4536952
    [No Abstract]   [Full Text] [Related]  

  • 11. The pharmacokinetics of phentermine and chlorphentermine in chronically treated rats.
    Lüllmann H; Rossen E; Seiler KU
    J Pharm Pharmacol; 1973 Mar; 25(3):239-43. PubMed ID: 4146324
    [No Abstract]   [Full Text] [Related]  

  • 12. [Influence of fenfluramine, chlorphentermine, and related compounds on the behavior of aggressive mice].
    Weischer ML; Opitz K
    Arch Int Pharmacodyn Ther; 1972 Feb; 195(2):252-9. PubMed ID: 5062780
    [No Abstract]   [Full Text] [Related]  

  • 13. The central hypotensive action of amphetamine, ephedrine, phentermine, chlorphentermine and fenfluramine.
    Hoyer I; Van Zwieten PA
    J Pharm Pharmacol; 1972 Jun; 24(6):452-8. PubMed ID: 4403827
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparative ultrastructural study of the effects of chlorphentermine and triparanol in rat lung and adrenal gland.
    Lüllmann H; Lüllmann-Rauch R; Reil GH
    Virchows Arch B Cell Pathol; 1973 Jan; 12(2):91-103. PubMed ID: 4351712
    [No Abstract]   [Full Text] [Related]  

  • 15. [Behavior of blood pressure during chronic effect of phenylalkylamines].
    Kemper F
    Arzneimittelforschung; 1969 Oct; 19(10):1702-4. PubMed ID: 5395371
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug-induced phospholipidosis. I. Lipid composition and chlorphentermine content of rat lung tissue and alveolar macrophages after chronic treatment.
    Schmien R; Seiler KU; Wassermann O
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 283(3):331-4. PubMed ID: 4276759
    [No Abstract]   [Full Text] [Related]  

  • 17. [Anorexigenic phenylalkylamines and serotonin metabolism].
    Opitz K
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 259(1):58-65. PubMed ID: 4233263
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug-induced phospholipidosis.
    Lüllmann H; Lüllmann-Rauch R; Wassermann O
    Ger Med; 1973; 3(3-4):128-35. PubMed ID: 4370610
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of anorexigenic and behavioral potency of phenylethylamines.
    Cox RH; Maickel RP
    J Pharmacol Exp Ther; 1972 Apr; 181(1):1-9. PubMed ID: 5066966
    [No Abstract]   [Full Text] [Related]  

  • 20. NMR-studies on the molecular basis of drug-induced phospholipidosis--II. Interaction between several amphiphilic drugs and phospholipids.
    Seydel JK; Wassermann O
    Biochem Pharmacol; 1976 Nov; 25(21):2357-64. PubMed ID: 999723
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.